Research Paper Volume 15, Issue 13 pp 6526—6544
N6AMT1 is a novel potential diagnostic, prognostic and immunotherapy response biomarker in pan-cancer
Figure 7. Correlations between N6AMT1 expression and immunomodulators: immunoinhibitors (A), immunostimulators (B) and MHC molecules (C). Red represents positive correlation and blue represents negative correlation. The most positively and negatively correlated cases are highlighted on the right.